Paul ashton

Paul ashton

Company: Inflammasome Therapeutics

Job title: President & Chief Executive Officer


Inhibiting Caspase-1 & Inflammasome Activation: Preclinical Data & Clinical Observations 11:00 am

Inhibiting caspase-1 and inflammasome activation in vivo Reversing cognitive decline in 5XFAD mice Clinical use associated with reduced incidence of ADRead more

day: Discovery Track Day 2 AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.